Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2026-03-01 @ 8:59 PM
Study NCT ID:
NCT01118234
Status:
COMPLETED
Last Update Posted:
2020-01-09
First Post:
2010-05-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
Sponsor:
Arbeitsgemeinschaft medikamentoese Tumortherapie
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Mabtenance
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |